CoDa's wound care product performs well in clinical trial

01/29/2013 | Interest.co.nz (New Zealand)

CoDa Therapeutics announced that its experimental drug Nexagon to treat chronic venous leg ulcers performed well in midstage clinical trials. The therapy aims to heal wounds faster and increase the incidence of wound healing compared with existing treatment options.

View Full Article in:

Interest.co.nz (New Zealand)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC